Concepedia

Author

Luigiana Luciano

Istituti di Ricovero e Cura a Carattere ScientificoORCID

Also Known As

L Luciano, L R Luciano, L. Luciano, Letícia Luciano, Luciano, Luigiana, Luigiana Luciano

142

Publications

2K

Citations

27

H-Index

59

Concepts

All Affiliations

Istituti di Ricovero e Cura a Carattere ScientificoSt. Eugenio HospitalFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoUniversity of BolognaUniversity of Bari Aldo Moro
LL

About

Luigiana Luciano is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, hematology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

17

22

793

2

Health Sciences

9

9

371

3

Cell Biology

4

4

155

4

Public Health

1

1

15

5

Cellular Therapies

1

1

39

Luigiana Luciano

×

42

Publications

1.6K

Citations

26

H-Index

YearCitations

Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib

Fabio Efficace, Michele Baccarani, Massimo Breccia,

Leukemia

2013

135

Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid Metaplasia.

Giovanni Barosi, Achille Ambrosetti, Antonietta Centra,

PubMed

1998

121

Residual Peripheral Blood CD26+ Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free Remission

Monica Bocchia, Anna Sicuranza, Elisabetta Abruzzese,

Frontiers in Oncology

2018

105

The hypereosinophilic syndrome: fluorescence in situ hybridization detects the del(4)(q12)-FIP1L1/PDGFRA but not genomic rearrangements of other tyrosine kinases.

Roberta La Starza, Giorgina Specchia, Antonio Cuneo,

PubMed

2005

66

Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real‐life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart

Giovanni Caocci, Olga Mulas, Elisabetta Abruzzese,

Hematological Oncology

2019

66

Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia

Roberto Latagliata, Massimo Breccia, Carmen Fava,

Hematological Oncology

2012

63

Fine needle aspiration biopsy of the spleen. A useful procedure in the diagnosis of splenomegaly.

Pio Zeppa, Antonio Vetrani, Luigiana Luciano,

PubMed

1994

61

Adherence and future discontinuation of tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia. A patient-based survey on 1133 patients

Massimo Breccia, Fabio Efficace, Simona Sica,

Leukemia Research

2015

61

Effects of cyclosporine on hematopoietic and immune functions in patients with hypoplastic myelodysplasia

Carmine Selleri, Jaroslaw P. Maciejewski, Lucio Catalano,

Cancer

2002

54

Outcome of 82 chronic myeloid leukemia patients treated with nilotinib or dasatinib after failure of two prior tyrosine kinase inhibitors

Andrea Rossi, Massimo Breccia, Elisabetta Abruzzese,

Haematologica

2012

50

Page 1